Cardio,Cardiovascular News,Cardiologists,Medicines,Heart Health,EKG

* Internet Search Results

*** Search Filter: "RhodeIsland"

武忠 - 四川大学华西医院 - 四川大学华西医院
武忠，主任医师，教授，医学博士，博士生导师，四川省卫计委学术技术带头人，中国医师协会心血管外科医师分会大血管学术委员会委员，中国研究型医院学会心脏瓣膜病学专业委员会委员，国家心血管病专家委员会微创心血管外科专业委员会委员，《中国胸心血管外科临床杂志》编委。武忠教授是华西医院心脏大血管外科冠脉外科和慢性肺栓塞外科亚专业学术带头人，擅长心脏瓣膜病 (包括瓣膜置换或成形手术)、冠心病 (冠状动脉旁路移植手术)、胸主动脉瘤 (主动脉夹层及真性动脉瘤)、慢性房颤 (迷宫手术)、慢性肺栓塞 (肺动脉内膜剥脱手术)的外科治疗以及微创心脏外科手术等。

心脏大血管外科 - 四川大学华西医院 - 四川大学华西医院
近十年来共培养心脏大血管外科专业人才400余人，其中博士41人，硕士32人，分布在全国各大心血管疾病中心工作。指导学生参加“大学生创新创业”、“互联网+”等各项教学竞赛、社会实践等，并取得了优异成绩。

胸外科专家介绍 - 四川大学华西医院 - 四川大学华西医院 - cd120
四川大学华西医院胸外科主任医师，教授，博士研究生导师，美国Emory大学肿瘤学博士后，美国癌诊研究协会会员（AACR），中华医学会胸心血管外科专委会青年委员，中华医学会创伤专委会委员，中国医师协会医学机器人医师分会委员，四川省医学会创伤专委会 ...

【封面新闻】大医堂｜川大华西医院心血管外科医生武忠 ...
四川大学华西医院心脏大血管外科党支部书记兼副主任，主任医师、教授，博士研究生导师，四川省学术技术带头人，中华医学会胸心血管外科分会冠脉学组委员、四川省医师协会心血管外科医师分会候任会长、四川省医学科技创新研究会心脏外科创新与转化 ...

武忠（四川大学华西医院心脏大血管外科党支部书记、副主任 ...
武忠，男，四川大学华西医院心血管外科医生，四川大学博士，教授，博士生导师，四川省卫计委学术技术带头人，前往美国克利夫兰心脏中心和英国剑桥大学访问学习。现任四川大学华西医院心脏大血管外科党支部书记、副主任，四川省医学科技创新研究会心脏外科创新与转化分会会长。

【中国大医生】全国著名心外科专家——华西医院安琪主任
现任：华西医院心脏大血管外科书记兼副主任、主任医师、博士生导师。兼任：四川省中华医学会胸心血管外科分会主任委员，中国医师协会心血管外科医师分会先心病学术委员会副主任委员等。专业专长：从事心脏外科临床工作近三十年，有丰富的心脏外科临床经验。擅长各类疑难重症先天性心脏病治疗 (包括各类婴幼儿及成人先天性心脏)，心脏瓣膜疾病的外科治疗，终末期心脏疾病的心脏移植治疗等。说明：华西医院，全称四川大学华西医院心脏大血管外科，是国家级重点学科，国家临床重点建设专科项目，在全国心外科排名中位列第六名，该科技术实力雄厚，专家众多，其中著名专家有：郭应强、胡佳、武忠、侯江龙、安琪等4位。

四川大学华西医院心脏大血管外科专家排名_四川大学华西医院 ...
四川大学华西医院心脏大血管外科专家名单共223位，为您提供在线问诊、咨询、预约挂号等服务。在这里还可以查询四川大学华西医院心脏大血管外科专家的简介、专业擅长、出诊时间等信息。

大医堂｜川大华西医院心血管外科医生武忠：刀尖上的“武者”
——擅长心脏瓣膜病、冠心病、胸主动脉瘤、慢性房颤、慢性肺栓塞的外科治疗以及微创心脏外科手术。 …… 但在患者眼里，武教授却是个平易近人、医术高超、最值得信赖的年轻“老专家”。说话做事与他行医风格一样，真实不掺一点假。

研究生部门户网站 - cd120
胡佳教授，主任医师，医学博士，博士生导师，华西医院心脏大血管外科副主任，大血管外科亚专科主任，深耕心血管外科领域20余年，尤其擅长各类胸腹主动脉疾病的微创手术治疗 (主动脉夹层及动脉瘤、主动脉壁内血肿、主动脉溃疡)；各类心脏瓣膜疾病、房颤微创外科治疗 (包括腔镜瓣膜置换或成形)；缺血性心脏病的外科治疗（冠心病外科治疗）。先后开展多项国际国内创新技术，是国内知名经验丰富的心脏大血管外科微创治疗专家之一。

肖锡俊_百度百科
从事心胸外科临床工作近30年，1996年起历任副主任医师、主任医师。 90年代末率先在西南地区开展心脏瓣膜病合并心房颤动外科治疗，年手术量超300例，主持四川省科技厅科研项目并参与国家课题，发表论文30余篇。

* Latest OCD 101 News

*** News Filter: "RhodeIsland"

Sister Marian Steffens O.C.D. Obituary May 16, 2026  O'Neill Funeral Homes
Are the Kids Alright in Rhode Island?  Rhode Island Monthly
Study expands access to childhood anxiety treatment in Newport County  Newport Daily News
Care New England introduces Butler Behavioral Health. What it means.  The Providence Journal
Go Teal for OCD Awareness Week  Rhode Island Monthly
Bradley Hospital enrolls children with anxiety, OCD for new study  WJAR
Sr. Mary Francine Davin Obituary December 11, 2020  O'Neill Funeral Homes
Brown researchers focus on expanding access to pediatric OCD treatment they helped pioneer  brown.edu
Newport Mental Health helping children take back lives from anxiety  Newport Daily News
Living a Horror Movie: Navigating Misconceptions About Postpartum OCD  Postpartum Support International
Bradley Hospital enrolling teens with OCD for brain stimulation research study  rinewstoday.com
MARIO DELLA GROTTA Obituary Jan 5, 2009  Nardolillo Funeral Home
Brain Signals Associated With OCD Discovered by Scientists For First Time  ScienceAlert
'I was horrified': Maine child diagnosed with disorder linked to ticks  KRCR
Bradley Hospital holds 'reunion' for intensive OCD program kids, families, clinicians  The Providence Journal

Common Cardiovascular Symptoms & Warning Signs

Chest Pain or Pressure (Angina) — Sensation of squeezing, fullness, or tightness in the center of the chest that may radiate to the jaw, neck, back, or arm.
Shortness of Breath (Dyspnea) — Difficulty breathing or feeling winded during routine activities, exertion, or while lying flat in bed.
Palpitations or Irregular Heartbeat — Sensations of a racing, fluttering, pounding, or skipping heart rate.
Unexplained Dizziness or Lightheadedness — Sudden feelings of faintness, loss of balance, or near-syncope linked to decreased blood flow to the brain.
Swelling in the Extremities (Edema) — Fluid retention causing notable swelling in the legs, ankles, feet, or abdomen.
Unusual Fatigue and Weakness — Persistent tiredness or exhaustion during simple daily tasks, often an early warning sign of heart failure.
Cold Sweats or Diaphoresis — Sudden onset of unexplained profuse sweating accompanied by chest discomfort or anxiety.
Cyanosis or Pale Skin Tone — A bluish or abnormally pale discoloration of the skin, lips, or nail beds due to poor oxygen circulation.
Persistent Coughing or Wheezing — Chronic cough producing white or pink blood-tinged mucus caused by fluid accumulation in the lungs.
Pain in the Extremities (Claudication) — Cramping or aching in the calves, thighs, or hips during walking, indicating peripheral artery disease.

Current Cardiovascular Treatments

Dual GIP/GLP-1 Receptor Agonists — Advanced metabolic agents like tirzepatide cut major adverse cardiovascular events, reduce systemic vascular inflammation, and improve heart failure outcomes.
Pulsed-Field Ablation (PFA) — Non-thermal electroporation therapy replacing traditional radiofrequency ablation to treat atrial fibrillation with greater tissue selectivity and safety.
SGLT2 Inhibitor Therapy — Guideline-directed medical treatment (e.g., dapagliflozin, empagliflozin) initiated early to reduce hospitalizations and mortality across heart failure spectrums.
Targeted siRNA & Lipid Gene Therapy — Small interfering RNA injectables (like inclisiran) and gene-editing therapies (VERVE-102) providing long-term LDL-C reduction with single-dose schedules.
Transcatheter Valve Therapies (TAVR / TMVR) — Minimally invasive catheter interventions for replacing or repairing severe aortic, mitral, and tricuspid valve stenosis/regurgitation without open-heart surgery.
Aldosterone Synthase Inhibitors — Targeted hormonal pathway medications, such as baxdrostat, designed to treat treatment-resistant hypertension by lowering aldosterone production.
Left Bundle Branch Area Pacing (LBBAP) — Conduction system pacing delivering direct physiological resynchronization as a superior alternative to traditional cardiac resynchronization therapy.
Dual Endothelin Receptor Antagonists — Novel oral therapies like aprocitentan used in combination regimes to target resistant high blood pressure through specialized vascular pathways.
Targeted Anti-Inflammatory Agents — Low-dose colchicine and specialized anti-inflammatory protocols aimed directly at preventing plaque rupture and reducing residual cardiovascular risk.
Mechanical Decompression Systems — Endovascular venous balloon technology and advanced left ventricular assist devices designed to acutely unload intracardiac pressures during heart failure crises.

Key Milestones in Cardiovascular History

Discovery of Blood Circulation (1628) — William Harvey published De Motu Cordis, demonstrating for the first time that blood circulates continuously through the body pumped by the heart.
Invention of the Stethoscope (1816) — René Laennec invented the wooden stethoscope, allowing physicians to auscultate and diagnose internal cardiac sounds non-invasively.
First Human Electrocardiogram (1902) — Willem Einthoven developed the string galvanometer to record the electrical activity of the heart, inventing the modern ECG.
First Human Cardiac Catheterization (1929) — Werner Forssmann performed the first successful cardiac catheterization on himself, opening the path for modern interventional cardiology.
Launch of the Framingham Heart Study (1948) — A landmark long-term epidemiological study began, establishing major risk factors like high blood pressure, cholesterol, and smoking.
Development of the Cardiopulmonary Bypass (1953) — John Gibbon successfully used a heart-lung machine on a human patient, enabling modern open-heart surgery.
First Successful Human Heart Transplant (1967) — Dr. Christiaan Barnard performed the world's first human-to-human heart transplant in Cape Town, South Africa.
First Coronary Angioplasty (1977) — Andreas Grüntzig performed the first successful percutaneous transluminal coronary angioplasty (PTCA) to open blocked arteries.
Introduction of Coronary Stents (1986) — Ulrich Sigwart and Jacques Puel implanted the first coronary stent in a human heart to prevent artery restenosis.
First TAVR Procedure (2002) — Alain Cribier performed the first Transcatheter Aortic Valve Replacement, revolutionizing treatment for aortic stenosis without open-heart surgery.

Current Cardiovascular Research & Breakthroughs

Gene-Editing for Lipid Lowering — Advanced base-editing and RNA therapies (such as VERVE-102) show potential for permanently reducing LDL cholesterol with single-dose targeted gene inactivation.
AI-Driven Predictive Diagnostics — Deep learning algorithms now evaluate polygenic risk scores and real-time imaging data to predict cardiac events years before clinical symptoms appear.
Stem Cell Remuscularization — Regenerative cardiac cell therapies using stem-cell-derived cardiomyocytes aim to repair post-infarct scar tissue and restore contractile function.
Pulsed-Field Ablation (PFA) — Non-thermal electroporation technology is transforming arrhythmia management by selectively isolating cardiac tissue with lower procedural risk.
Anti-Inflammatory Therapies — Target-specific anti-inflammatory drugs are being validated to reduce residual vascular risk and suppress ongoing atheroma plaque progression.
Transcatheter Valve Evolution (TMVR/TAVR) — Next-generation transcatheter systems are expanding treatment options for complex structural valve conditions without traditional open surgery.
Digital Twin Hemodynamic Modeling — Virtual patient-specific cardiac models integrate imaging and biomarkers to simulate interventional outcomes before execution.
Conduction System Pacing (LBBAP) — Left bundle branch area pacing is replacing traditional biventricular pacing to provide more natural physiological resynchronization.
Cardioprotective Metabolic Drugs — Broadening applications of SGLT2 inhibitors and GLP-1 receptor agonists demonstrate significant reductions in heart failure admissions and vascular events.
Novel Aldosterone Synthase Inhibitors — New drug classes like Baxdrostat provide target-specific control for resistant hypertension by directly modulating hormone pathways.